Thomas Strungmann

Thomas Strungmann


Tegernsee, Germany (DE)
Thomas Strüngmann founded generic drug maker Hexal AG in 1986. In 2005, he and his brother Andreas sold Hexal for $6.7B. They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine. They own approximately 50% of the company as well as significant ownership in 4SC and Immatics.
Thomas Strüngmann founded generic drug maker Hexal AG in 1986. In 2005, he and his brother Andreas sold Hexal for $6.7B. They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine. They own approximately 50% of the company as well as significant ownership in 4SC and Immatics.
View in Google Earth Homes - Celebrity - Business
Links: www.superyachtfan.com
By: nmelesko

Advertisement

Advertisement

Celebrity Homes Mailing List

Comments

Policies
Please enable images and enter code to post
Reload

Advertisement